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The Editorial on the Research Topic
The Emerging Role of Monocyte-Derived Cells in the Central Nervous System
Hematopoietic stem cells (HSCs) with self-renewal potential differentiate in contact with flowing 
blood and during embryonic development give rise to all blood cell types. Neuroinflammation is 
a pathological process frequently associated with tissue damage, which plays role in the clearance 
of pathogens and in repair mechanisms. In an original article (Wlodarczyk et al.), the authors sug-
gest that beneficial or pathological outcomes of MS and EAE is the consequence of myeloid cell 
heterogeneity comprising resident microglia, infiltrating bone marrow (BM)-derived monocytes, 
macrophages, and dendritic cells (DCs). The CX3CR1 receptor and its ligand CX3CL1 are expressed 
in microglia and contribute to neuroinflammation. Disrupting this regulatory axis may result in 
abnormal microglial activation leading to earlier onset and higher incidence of disease manifestation. 
Phenotypic and functional analyses revealed that CD11c(+) and CD11c(−) microglia and CD11c(+) 
blood cells represent functionally different populations exhibiting pathological and protective func-
tions in line with inflammatory gene expression profiles. At the peak of EAE, a subpopulation of 
microglia expresses IFNβ that confers protection verified by upregulated CSF-1 production.
Dendritic cells represent a diverse population of cells, which continuously sense and digest soluble/
particulate antigens and their migratory potential helps to eliminate harmful tissue/cell components. 
Recent data revealed that microglia acquires a dysfunctional rather an activated phenotype causing 
defective clearance of harmful structures together with the loss of neuronal support, whereas sys-
temic inflammation causes the exacerbation of neurodegenerative diseases. The perspective article 
by Bossù et al. focuses on the collaboration of the immune and the nervous systems with emphasis 
on the elimination of harmful material linked to inflammation and neuronal loss. These processes 
also disturb the blood–brain barrier leading to vascular dysfunction through peripheral cells. Recent 
evidence suggests that blood monocytes are associated with familiar and sporadic forms of AD 
and PD, and CD33 and TREM2 gene variants have been identified as risk factors of AD associated 
with PD and coupled with myeloid cells, which infiltrate the degenerated brain, while the clearance 
of vascular Aβ is carried out by patrolling monocytes. According to a recent report by Louveau 
et al. (1) found that the CNS is monitored by unique immune surveillance mechanisms showing 
that the trafficking of leukocytes into the CNS through lymphatic vessels provides a novel route 
for the entrance/exit of various cell types, among them DC subsets supporting regulatory events. 
State-of-the-art techniques may help to identify DC functions at levels of initiation and/or regula-
tion during brain-specific immune responses. Potential targets for therapeutic approaches may rely 
on DC-based vaccination strategies rather than modifying ongoing immune responses. Optimized 
immunization protocols to eliminate accumulated misfolded proteins may offer novel means to 
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decrease pathological consequences in the CNS. In this context, 
Ab-sensitized DCs have successfully been applied to reduce Aβ 
accumulation and attenuate cognitive deficit.
Circulating extracellular macrovesicles (EVs) have been shown 
to contribute many disorders and elevated numbers of shedding 
vesicles in plasma and/or in body fluids have also been identified. 
Importantly, the appearance of these vesicles correlates with acute 
or active phase of diseases and can be used as predictive and/
or diagnostic biomarkers for pathological conditions. As a novel 
aspect, the article by Nigro et  al. addressed the question how 
intracellular vesicles could modify the outcome of MS at the pro-
gressive phase of the disease and in classical neurodegenerative 
conditions including AD and PD. The molecular composition of 
shedding vesicles and exosomes was found to be heterogeneous 
and contain signaling molecules, receptors, integrins, cytokines, 
bioactive lipids, nucleic acids, and organelles thus acquiring the 
potential to modify the activities of the recipient cells. Despite 
considerable heterogeneity of exosomes, their cellular origin is 
shared. This study also demonstrates that the increase of EVs, 
derived from myeloid cells of AD patients and with mild cogni-
tive impairment, correlates with classical biomarkers of neuronal 
injury demonstrating the diagnostic potential of EVs. When 
microglia-derived EVs were exposed to the amyloid-β1–42 peptide, 
soluble neurotoxic species derived from extracellular insoluble 
aggregates were generated, which exhibited potent neurotoxicity. 
This finding, in line with the observation that activated microglia 
surround amyloid deposits, suggests the involvement of cell-
to-cell communication supporting the spread of amyloid-β1–42 
pathology throughout the brain.
The etiology of MS has been associated with both genetic 
predisposition and environmental factors, including exogenous 
retroviruses, which have acquired the capability to get integrated 
into human germ line cells and transmit them over generations 
through Mendelian trait. MS is associated with HERV-H, K, 
W retroviruses commonly referred to as MSRV. The article by 
Morandi et  al. suggests that HERVs act as pathogenic factors 
linking the individuals’ genetic susceptibility to CNS autoim-
munity and infections acting as disease triggers. In most cases, 
although retroviruses are silenced or expressed at low levels, 
they may increase expression. HERVs are expressed in mono-
cytes, microglia, and within CNS lesions of MS patients, and 
upon TLR4 receptor-mediated activation they produce pro-
inflammatory cytokines, reduce myelin expression, and cause 
death of oligodendrocyte precursors. MS is the most common 
cause of neurological disability in young adults manifested as a 
chronic demyelinating process in the CNS with inflammatory 
and degenerative changes in the brain and spinal cord. During 
MS, high level of HERV-W/MSRV promotes disease progression 
increasing with time of relapses confirming its association with 
HERV-W/MSRV.
Epigenetic states are defined at the level of DNA and 
chromatin modifications and by RNA editing processes. 
The state-of-the-art review by Papavasiliou et  al. discusses 
the advantage of newly developed technologies that allow 
capturing the epigenetic status of individual genes in a 
time-dependent manner thus providing information on tran-
scriptional responses during development and in response 
to environmental stimuli. The authors of this article discuss 
how epigenetic modulations may affect the development of a 
healthy brain as opposed to neurodegenerative diseases and 
aging. For example, DNA methylation is an epigenetic modifi-
cation, which regulates X chromosome inactivation, cell fate, 
chromosomal instability, repression of transposable elements, 
and gene expression during lifetime of the organism. The level 
of CpG methylation inversely correlates with gene expression 
and controls transcription either locally or through occluding 
transcription factor binding sites within promoter regions. 
This is accomplished via binding DNA and interfering with 
transcriptional elongation, or globally through methylation of 
CpG-rich regions leading to the recruitment of proteins that 
alter the chromatin state and result in general locus silencing. 
Covalent modifications impact gene expression levels and 
respond to environmental stimuli such as migration of cells 
to the site of infection or into lymph nodes guided by the 
chemokine CCL2. According to a recent report, this process 
is supported by the coactivator protein IκBz supporting the 
action of CCL2 (2). In conclusion, the mechanisms outlined 
in this issue demonstrate the emerging importance of future 
investigations into the very nature of neuroimmune commu-
nication. Targeting monocyte-derived cells in the CNS offers 
a promising and novel approach for designing immunomodu-
latory strategies that may offer potent treatment options for 
neuro- and psychiatric diseases.
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